|
|
|
Emanuel Petricoin III MD, PhD |
Professor |
Email: epetrico@gmu.edu |
Website: http://www.gmu.edu/departments/lifesciences/proteomics/petricoin.htm |
Work Phone: 703-993-8646 |
Fax: 703-993-4288 |
Office: 181A Discovery Hall |
| |
BioSketch:
|
| |
Academic Background:
Petricoin holds a doctorate in microbiology from the University of Maryland at College Park |
| |
Research Interests:
Together with Dr. Lance Liotta, he has formed the Center for Applied Proteomics and Molecular Medicine. The Center has formed a unique partnership between George Mason and Inova Health System. George Mason University-Inova Health System Translational Research Centers is a joint initiative to coordinate multiple programs to implement proteomics, nanotechnology, and genomics research in cancer, metabolic syndrome, cardiopulmonary diseases, and neurodegenerative and liver diseases. This initiative comprises the research efforts of three shared centers: the Center for Applied Proteomics and Molecular Medicine; the Center for Biomedical Genomics; and the Center for the Study of Genomics of Liver Diseases. Inova and George Mason have combined efforts to recruit internationally renowned scientists, such as Lance Liotta and Emanuel Petricoin III, to work closely with clinical investigators from Inova. |
| |
| Recent Publications |
| Mathematical modeling of the cancer cell's control circuitry: paving the way to patient-tailored combination therapy |
| RP Araujo EF Petricoin III LA Liotta |
| Current Signal Transduction Therapies 2007 (in press) |
| |
| The amplified peptidome: the new treasure chest of candidate biomarkers |
| DH Geho LA Liotta EF Petricoin III W Zhou RP Araujo |
| Curr. Opin. Chem. Biol. 2006 10 1 50 |
| |
| Network-targeted combination therapy: a new concept in cancer treatment |
| RP Araujo C Doran LA Liotta EF Petricoin III |
| Drug Discovery Today: Therapeutic Strategies 2005 1 4 425 |
| |
| A mathematical model of combination therapy using the EGFR signaling network |
| RP Araujo EF Petricoin III LA Liotta |
| Biosystems 2005 80 1 57 |
| |
| Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. |
| EF Petricoin III D Ornstein LA Liotta |
| Urol Oncol 2004 22 322 |
| |